摘要
PurposeEsophagectomy for esophageal cancer has a high incidence rate of early postoperative recurrence and death. This study aimed to identify the clinical and pathological features in early recurrence cases and to confirm the usefulness of prediction using these factors for effective adjuvant therapy and postoperative surveillance.MethodsOne hundred and twenty five patients who developed postoperative recurrence after undergoing radical esophagectomy for thoracic esophageal cancer were classified into two groups as follows: those with early recurrence at <= 6 months and those with nonearly recurrence at > 6 months after surgery. After identifying related factors of early recurrence, usefulness of these factors for prediction were examined in all patients with and without recurrence.ResultsThe analysis cohort consisted of 43 and 82 patients in the early and nonearly recurrence groups, respectively. In multivariate analysis, factors associated with early recurrence were higher initial levels of tumor markers (squamous cell carcinoma [SCC] >= 1.5 ng/ml in tumors, except for adenocarcinoma, and carcinoembryonic antigen [CEA] >= 5.0 ng/ml in adenocarcinoma) and higher venous invasion (v), i.e., >= 2 (p = 0.040 and p = 0.004, respectively). The usefulness of these two factors for recurrence prediction was confirmed in 378 patients, including 253 patients without recurrence. Patients with at least one of the two factors had significantly higher early recurrence rates than those without any factors in pStages II and III (odds ratio [OR], 6.333; p = 0016 and OR, 4.346; p = 0.008, respectively).ConclusionsEarly recurrence of thoracic esophageal cancer (i.e., during <= 6 months after esophagectomy) was associated with higher initial tumor marker levels and pathological findings of v >= 2. The combination of these two factors is useful as a simple and critical predictor of early postoperative recurrence.
学科与关键词
- The clinical significance of the intraoperative pathological examination of bilateral recurrent laryngeal nerve lymph nodes using frozen sections in cervical field lymph node dissection of thoracic esophageal squamous cell carcinoma.Xu, Jinxin; Zheng, Bin; Zhang, Shuliang; Zeng, Taidui; Chen, Hao; Zheng, Wei; Chen, ChunJournal of Thoracic Disease, 2019, 11(8): 3525-3533.被引 5
- Predictive Value of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Monocyte-to-Lymphocyte Ratio Esophageal Stricture After Endoscopic Submucosal Dissection of Early Esophageal CancerLiu, Shasha; Li, Zenghui; Guo, Weina; Liu, Zhonghong; Fan, Yujing*MEDICAL SCIENCE MONITOR, 2023, 29: e940041.被引 1
- A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapyZhou, Zihao; Huang, Shujie; Ben, Xiaosong; Zhuang, Weitao; Hong, Liangli; Xie, Zefeng; Zhang, Dongkun; Xie, Liang; Zhou, Haiyu; Tang, Jiming; Chen, Gang; Wu, Hansheng*; Qiao, Guibin*Annals of Translational Medicine, 2022, 10(4).被引 1
